Company research
REVVITY, INC.
CIK 31791Updated Sep 27, 2026
SecurityRVTY · NYSE · equity
Name history
PERKINELMER INC · through Apr 14, 2023EG&G INC · through Jul 26, 1999
RVTY price & chart
Loading TradingView…
NYSE:RVTY on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 12,168,411,000Source | 12,392,478,000Source | 13,564,665,000Source | 15,000,554,000Source |
| Property, Plant and Equipment, NetUSD | 479,249,000Source | 482,217,000Source | 509,654,000Source | 545,605,000Source |
| GoodwillUSD | 6,613,493,000Source | 6,463,619,000Source | 6,533,550,000Source | 7,416,584,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,347,003,000Source | 2,640,921,000Source | 3,022,321,000Source | 4,063,104,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 919,860,000Source | 1,163,396,000Source | 913,163,000Source | 618,319,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 744,671,000Source | 632,400,000Source | 632,811,000Source | 1,023,792,000Source |
| Inventory, NetUSD | 379,497,000Source | 367,587,000Source | 428,062,000Source | 624,714,000Source |
| Assets, CurrentUSD | 2,239,747,000Source | 2,349,608,000Source | 3,001,091,000Source | 2,440,780,000Source |
| Operating Lease, Right-of-Use AssetUSD | 165,439,000Source | 167,716,000Source | 155,083,000Source | 207,775,000Source |
| Other Assets, NoncurrentUSD | 323,480,000Source | 288,397,000Source | 342,966,000Source | 326,706,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 4,918,051,000Source | 4,725,604,000Source | 5,691,926,000Source | 7,859,309,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 112,281,000Source | 120,646,000Source | 123,426,000Source | 126,241,000Source |
| Retained Earnings (Accumulated Deficit)USD | 6,054,314,000Source | 5,845,223,000Source | 5,609,212,000Source | 4,417,174,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -222,135,000Source | -396,105,000Source | -276,692,000Source | -162,692,000Source |
| Stockholders' Equity Attributable to ParentUSD | 7,250,360,000Source | 7,666,874,000Source | 7,872,739,000Source | 7,141,245,000Source |
| Additional Paid in Capital, Common StockUSD | 1,305,900,000Source | 2,097,110,000Source | 2,416,793,000Source | 2,760,522,000Source |
| Liabilities and EquityUSD | 12,168,411,000Source | 12,392,478,000Source | 13,564,665,000Source | 15,000,554,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,331,246,000Source | 653,100,000Source | 1,450,463,000Source | 1,213,744,000Source |
| Accounts Payable, CurrentUSD | 185,464,000Source | 167,463,000Source | 204,121,000Source | 355,458,000Source |
| Operating Lease, Liability, NoncurrentUSD | 148,108,000Source | 151,505,000Source | 132,747,000Source | 185,359,000Source |
| Other Liabilities, NoncurrentUSD | 807,461,000Source | 770,523,000Source | 930,946,000Source | 1,480,469,000Source |
| Additional Financial Items | ||||
| Accounts Receivable, after Allowance for Credit LossUSD | 782,679,000Source | 660,563,000Source | 662,404,000Source | 1,054,095,000Source |
| Accrued Liabilities, CurrentUSD | 556,954,000Source | 485,395,000Source | 524,470,000Source | 854,046,000Source |
| AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD | -275,000Source | -369,000Source | -216,000Source | -40,000Source |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD | 798,000Source | 798,000Source | 798,000Source | 842,000Source |
| Deferred Revenue, CurrentUSD | 160,194,000Source | 140,212,000Source | 135,555,000Source | 226,331,000Source |
| Deferred Tax Liabilities, NetUSD | 454,602,000Source | 450,490,000Source | 568,502,000Source | 871,808,000Source |
| Dividends PayableUSD | — | — | 8,600,000Source | 8,800,000Source |
| Long-term Debt, Current MaturitiesUSD | 588,828,000Source | 242,000Source | 721,872,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 2,631,236,000Source | 3,150,476,000Source | 3,177,770,000Source | 4,979,737,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 405,340,000Source | 427,849,000Source | 431,769,000Source | 358,004,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 22,847,000Source | 37,809,000Source | 41,410,000Source | 32,780,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 101,023,000Source | 15,969,000Source | -8,997,000Source | 155,391,000Source |
| Increase (Decrease) in InventoriesUSD | -14,782,000Source | -45,086,000Source | -14,109,000Source | 2,376,000Source |
| Increase (Decrease) in Accounts PayableUSD | 7,345,000Source | -26,025,000Source | -76,426,000Source | 823,000Source |
| Deferred Income Tax Expense (Benefit)USD | -61,483,000Source | -102,232,000Source | -123,664,000Source | -49,342,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 582,933,000Source | 628,299,000Source | 91,272,000Source | 1,410,750,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -17,353,000Source | 776,162,000Source | 1,313,524,000Source | -4,112,758,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 73,522,000Source | 86,648,000Source | 81,368,000Source | 99,888,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 820,815,000Source | 369,578,000Source | 388,882,000Source | 73,072,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -857,523,000Source | -1,128,235,000Source | -947,121,000Source | -2,941,657,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 32,800,000Source | 34,454,000Source | 34,966,000Source | 32,373,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -243,422,000Source | 250,079,000Source | 443,627,000Source | 216,723,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 921,030,000Source | 1,164,452,000Source | 914,373,000Source | 619,337,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 86,195,000Source | 91,092,000Source | 94,008,000Source | 54,120,000Source |
| Income Taxes Paid, NetUSD | 131,350,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 48,521,000Source | -26,147,000Source | -14,048,000Source | -22,926,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 22,847,000Source | 37,809,000Source | 41,410,000Source | 32,780,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 4,552,000Source | 6,073,000Source | 7,349,000Source | 4,962,000Source |
| Amortization of Intangible AssetsUSD | 335,600,000Source | 359,400,000Source | 365,100,000Source | 290,200,000Source |
| DepreciationUSD | 69,755,000Source | 68,473,000Source | 66,700,000Source | 67,300,000Source |
| Dividends PayableUSD | — | — | 8,600,000Source | 8,800,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | -273,000Source | 1,059,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | 0Source | — | 0Source |
| GoodwillUSD | 6,613,493,000Source | 6,463,619,000Source | 6,533,550,000Source | 7,416,584,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 239,883,000Source | 283,071,000Source | 179,503,000Source | 943,283,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | 1,318,000Source | -12,686,000Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 513,591,000Source | -126,000Source |
| Income Tax Expense (Benefit)USD | 28,394,000Source | 33,055,000Source | 3,473,000Source | 336,603,000Source |
| InterestExpenseNonoperatingUSD | 92,185,000Source | 96,278,000Source | — | — |
| Investment Income, InterestUSD | 31,103,000Source | 73,190,000Source | 72,131,000Source | 2,241,000Source |
| Net Income (Loss) Attributable to ParentUSD | 241,201,000Source | 270,385,000Source | 693,094,000Source | 943,157,000Source |
| Nonoperating Income (Expense)USD | -88,358,000Source | -30,615,000Source | -117,586,000Source | -52,492,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -37,977,000Source | -3,357,000Source |
| Payments to Acquire InvestmentsUSD | — | — | 6,300,000Source | 23,130,000Source |
| Restructuring CostsUSD | 55,932,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 2,856,051,000Source | 2,755,026,000Source | 2,750,571,000Source | 5,067,169,000Source |
| Selling, General and Administrative ExpenseUSD | 991,890,000Source | 994,074,000Source | 1,022,551,000Source | 1,227,521,000Source |
| Operating Income (Loss)USD | 356,635,000Source | 346,741,000Source | 300,562,000Source | 1,332,378,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -37,977,000Source | -3,357,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 268,277,000Source | 316,126,000Source | 182,976,000Source | 1,279,886,000Source |
| Income Tax Expense (Benefit)USD | 28,394,000Source | 33,055,000Source | 3,473,000Source | 336,603,000Source |
| Net Income (Loss) Attributable to ParentUSD | 241,201,000Source | 270,385,000Source | 693,094,000Source | 943,157,000Source |
| Earnings Per Share, BasicUSD per share | 2.07Source | 2.21Source | 5.56Source | 8.12Source |
| Earnings Per Share, DilutedUSD per share | 2.07Source | 2.2Source | 5.55Source | 8.08Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 116,542,000Source | 122,756,000Source | 124,704,000Source | 116,165,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 116,595,000Source | 122,822,000Source | 124,812,000Source | 116,674,000Source |
| Interest Expense (non-operating)USD | 92,185,000Source | 96,278,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 335,600,000Source | 359,400,000Source | 365,100,000Source | 290,200,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | 69,200,000Source | 97,500,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 0.28Source | 0.28Source | 0.28Source | — |
| Current Income Tax Expense (Benefit)USD | 89,877,000Source | 135,287,000Source | 127,137,000Source | 385,945,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 239,883,000Source | 283,071,000Source | 179,503,000Source | 943,283,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 142,633,000Source | 134,177,000Source | 51,314,000Source | 562,704,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | 2.06Source | 2.31Source | 1.44Source | 8.12Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | 2.06Source | 2.3Source | 1.44Source | 8.08Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | 1,318,000Source | -12,686,000Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 513,591,000Source | -126,000Source |
| Investment Income, InterestUSD | 31,103,000Source | 73,190,000Source | 72,131,000Source | 2,241,000Source |
| Nonoperating Income (Expense)USD | -88,358,000Source | -30,615,000Source | -117,586,000Source | -52,492,000Source |
| Research and Development ExpenseUSD | 215,840,000Source | 196,844,000Source | 216,578,000Source | 274,969,000Source |
| Restructuring CostsUSD | 55,932,000Source | — | — | — |
Filing attachments
d915642dex991.htm · 8-K · 2025-01-07
EX-99.1 2 d915642dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 EXECUTION VERSION CUSIP Numbers: Deal: 76156EAA9 Revolver: 76156EAB7 CREDIT AGREEMENT Dated as of January 7, 2025 among REVVITY, INC., REVVITY HEALTH SCIENCES, INC., and CERTAIN OTHER SUBSIDIARIES OF REVVITY, INC., as the Borrowers, BANK OF AMERICA, N.A., as the Administrative Agent, the Swing Line Lender and an L/C Issuer, JPMORGAN CHASE BANK, N.A., GOLDMAN SACHS BANK USA, PNC BANK, NATIONAL ASSOCIATION, and WELLS …
Read attachment ↗